My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    Perspectives in the treatment of breast cancer: 1976.

    [No authors listed]

    Ann Intern Med. 1977 Jun;86(6):784-98.PMID: 869360 [PubMed - indexed for MEDLINE]Related articles

    2.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.PMID: 17993229 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

    Early Breast Cancer Trialists' Collaborative Group (EBCTCG).

    Lancet. 2005 May 14-20;365(9472):1687-717.PMID: 15894097 [PubMed - indexed for MEDLINE]Related articles

    4.

    The curability of breast cancer and the treatment of advanced disease.

    Guarneri V, Conte PF.

    Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S149-61. Epub 2004 Apr 24. Review.PMID: 15107948 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of breast cancer in countries with limited resources.

    Carlson RW, Anderson BO, Chopra R, Eniu AE, Jakesz R, Love RR, Masetti R, Schwartsmann G; Global Summit Treatment Panel.

    Breast J. 2003 May-Jun;9 Suppl 2:S67-74.PMID: 12713499 [PubMed - indexed for MEDLINE]Related articles

    6.

    Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.

    Hoffmann J, Sommer A.

    J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):191-200. Epub 2005 Jan 28.PMID: 15860262 [PubMed - indexed for MEDLINE]Related articles

    7.

    Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.

    Fisher BJ, Perera FE, Cooke AL, Opeitum A, Stitt L.

    Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):117-23.PMID: 9747828 [PubMed - indexed for MEDLINE]Related articles

    8.

    Management of breast cancer.

    Cohen IA, Keller JH, Abate MA.

    Clin Pharm. 1982 Nov-Dec;1(6):515-29. Review.PMID: 6192963 [PubMed - indexed for MEDLINE]Related articles

    9.

    Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.

    Carlson RW, Henderson IC.

    Breast Cancer Res Treat. 2003;80 Suppl 1:S19-26; discussion S27-8. Review.PMID: 14535531 [PubMed - indexed for MEDLINE]Related articles

    10.

    The prognostic role of progesterone receptors in human breast cancer.

    McGuire WL, Clark GM.

    Semin Oncol. 1983 Dec;10(4 Suppl 4):2-6.PMID: 6669985 [PubMed - indexed for MEDLINE]Related articles

    11.

    Breast cancer treatment--current status. 4. Adjuvant therapy.

    Mitchell MS.

    Postgrad Med. 1983 Sep;74(3):161-5, 168-72, 174-5.PMID: 6193503 [PubMed - indexed for MEDLINE]Related articles

    12.

    Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.

    Buzdar AU.

    Oncologist. 2003;8(4):335-41. Review.PMID: 12897330 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer.

    Nomura Y, Tashiro H, Shinozuka K.

    Cancer. 1985 Feb 1;55(3):546-51.PMID: 3965108 [PubMed - indexed for MEDLINE]Related articles

    14.

    Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer.

    Dalberg K, Mattsson A, Sandelin K, Rutqvist LE.

    Breast Cancer Res Treat. 1998 May;49(1):69-78.PMID: 9694613 [PubMed - indexed for MEDLINE]Related articles

    15.

    Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.

    Taghian AG, Jeong JH, Mamounas EP, Parda DS, Deutsch M, Costantino JP, Wolmark N.

    J Clin Oncol. 2006 Aug 20;24(24):3927-32.PMID: 16921044 [PubMed - indexed for MEDLINE]Related articles

    16.

    Reducing the risk of late recurrence in hormone-responsive breast cancer.

    Cufer T.

    Ann Oncol. 2007 Sep;18 Suppl 8:viii18-25. Review.PMID: 17890210 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fundamental research leading to improved endocrine therapy for breast cancer.

    Miller WR.

    J Steroid Biochem. 1987;27(1-3):477-85. Review.PMID: 3320538 [PubMed - indexed for MEDLINE]Related articles

    18.

    Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control?

    Ballo MT, Strom EA, Prost H, Singletary SE, Theriault RL, Buchholz TA, McNeese MD.

    Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):105-12.PMID: 10219802 [PubMed - indexed for MEDLINE]Related articles

    19.

    Chemotherapy of breast cancer.

    Perlow LS, Holland JF.

    Med Oncol Tumor Pharmacother. 1984;1(3):169-92. Review.PMID: 6400037 [PubMed - indexed for MEDLINE]Related articles

    20.

    Challenges in the endocrine management of breast cancer.

    Mouridsen HT, Rose C, Brodie AH, Smith IE.

    Breast. 2003 Aug;12 Suppl 2:S2-19. Review.PMID: 14659138 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity